Peer Review Committee for Experimental Therapeutics (ET)

Areas reviewed

  • Isolation, testing, and synthesis of natural products
  • Modification and development of drugs
  • Toxicity and effectiveness of therapeutic agents and drug delivery systems (including nanotechnology- and microbial-based strategies)
  • Molecular imaging for pre-clinical therapeutic development
  • Pharmacology/pharmacogenetics/pharmacogenomics
  • Gene therapies and gene target validation

Committee members are being determined and will be announced in 2021.